Hyoscine butylbromide administered at the cecum increases polyp detection: A randomized double-blind placebo-controlled trial

Endoscopy

Volumn 44, Issue 10, 2012, Pages 917-922

  Corte, C ^a   Dahlenburg, L ^a   Selby, W ^a   Griffin, S ^a   Byrne, C ^a   Chua, T ^a   Kaffes, A ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; MIDAZOLAM; PLACEBO; PROPOFOL; SCOPOLAMINE BUTYL BROMIDE;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; COLON POLYP; COLONOSCOPE; COLONOSCOPY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPASMOLYSIS;

BUTYLSCOPOLAMMONIUM BROMIDE; CECUM; COLONIC POLYPS; COLONOSCOPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PLACEBOS; STATISTICS, NONPARAMETRIC;

EID: 84866343511     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0032-1310009     Document Type: Article

References (61)

1. Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer: 2010; 127 2893 2917
2. Jemal A, Center MM, De Santis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev: 2010; 19 1893 1907
3. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. CA: A Cancer Journal for Clinicians: 2006; 56 106 130
4. Winawer SJ, Zauber AG, Ho MN. The National Polyp Study Workgroup et al. Prevention of colorectal cancer by colonoscopic polypectomy. New Engl J Med: 1993; 329 1977
5. Winawer S, Fletcher R, Rex D et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology: 2003; 124 544 560
6. Winawer SJ, Fletcher RH, Miller L et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology: 1997; 112 594 642
7. ACN Colorectal Cancer (CRC) Working Party Guidelines for the prevention, early detection and management of colorectal cancer. Sydney The Cancer Council Australia and Australian Cancer Network: 2005
8. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology: 2008; 134 1570 1595
9. Excellence NIfHaC Improving outcomes in colorectal cancers. London National Institute for Health and Clinical Excellence: 2004
10. van Rijn JC, Reitsma JB, Stoker J et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol: 2006; 101 343 350
11. Hixson LJ, Fennerty MB, Sampliner RE, Garewal HS. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc: 1991; 37 125 127
12. Rex DK, Cutler CS, Lemmel GT et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology: 1997; 112 24 28
13. Matsushita M, Hajiro K, Okazaki K et al. Efficacy of total colonoscopy with a transparent cap in comparison with colonoscopy without the cap. Endoscopy: 1998; 30 444 447
14. Rex DK, Chadalawada V, Helper DJ. Wide angle colonoscopy with a prototype instrument: impact on miss rates and efficiency as determined by back-to-back colonoscopies. Am J Gastroenterol: 2003; 98 2000 2005
15. Harrison M, Singh N, Rex DK. Impact of proximal colon retroflexion on adenoma miss rates. Am J Gastroenterol: 2004; 99 519 522
16. Hixson LJ, Fennerty MB, Sampliner RE et al. Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst: 1990; 82 1769 1772
17. Froehlich F, Wietlisbach V, Gonvers JJ et al. Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc: 2005; 61 378 384
18. Harewood GC, Sharma VK, de Garmo P. Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc: 2003; 58 76 79
19. Parra-Blanco A, Nicolas-Perez D, Gimeno-Garcia A et al. The timing of bowel preparation before colonoscopy determines the quality of cleansing, and is a significant factor contributing to the detection of flat lesions: a randomized study. World J Gastroenterol: 2006; 12 6161 6166
20. Rex DK. Colonoscopic withdrawal technique is associated with adenoma miss rates. Gastrointest Endosc: 2000; 51 33 36
21. Barclay RL, Vicari JJ, Doughty AS et al. Colonoscopic Withdrawal Times and Adenoma Detection during Screening Colonoscopy. New Engl J Med: 2006; 355 2533 2541
22. Simmons DT, Harewood GC, Baron TH et al. Impact of endoscopist withdrawal speed on polyp yield: implications for optimal colonoscopy withdrawal time. Aliment Pharmacol Ther: 2006; 24 965 971
23. Sanchez W, Harewood GC, Petersen BT. Evaluation of polyp detection in relation to procedure time of screening or surveillance colonoscopy. Am J Gastroenterol: 2004; 99 1941 1945
24. Corte CJ, Kim AH, Kaffes AJ. M1417: Objective measures of colonoscopic difficulty: correlation with polyp detection and operator perception. Gastrointest Endosc: 2010; 71 AB215 AB216
25. Pickhardt PJ, Nugent PA, Mysliwiec PA et al. Location of adenomas missed by optical colonoscopy. Ann Intern Med: 2004; 141 352 359
26. Froehlich F. Colonoscopy: antispasmodics not only for premedication, but also during endoscope withdrawal? Gastrointest Endosc: 2000; 51 379
27. Lee JM, Cheon JH, Park JJ et al. Effects of Hyosine N-butyl bromide on the detection of polyps during colonoscopy. Hepatogastroenterology: 2010; 57 90 94
28. Brown S, Baraza W, Hurlstone P. Chromoscopy versus conventional endoscopy for the detection of polyps in the colon and rectum. Cochrane Database Syst Rev: 2007; 04 CD006439
29. Leufkens AM, DeMarco DC, Rastogi A et al. Effect of a retrograde-viewing device on adenoma detection rate during colonoscopy: the TERRACE study. Gastrointest Endosc: 2011; 73 480 489
30. Leung F, Harker J, Leung J et al. Removal of infused water predominantly during insertion (water exchange) is consistently associated with an increase in adenoma detection rate - review of data in randomized controlled trials (RCTs) of water-related methods. J Interv Gastroenterol: 2011; 1 121 126
31. Leung FW. Water exchange may be superior to water immersion for colonoscopy. Clin Gastroenterol Hepatol: 2011; 9 1012 1014
32. Tytgat GN. Hyoscine butylbromide - a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures. Curr Med Res Opin: 2008; 24 3159 3173
33. Grainger SL, Smith SE. Dose-response relationships of intravenous hyoscine butylbromide and atropine sulphate on heart rate in healthy volunteers. Br J Clin Pharmacol: 1983; 16 623 626
34. Gonzalez-Mendiola R, Sanchez Fernandez C, Prieto Montano P et al. Acute urticaria induced by hyoscine butylbromide. Allergy: 2004; 59 787 788
35. Treweeke P, Barrett NK. Allergic reaction to Buscopan. Br J Radiol: 1987; 60 417 418
36. Altintas E, Ucbilek E, Sezgin O, Sayici Y. Alverine citrate plus simethicone reduces cecal intubation time in colonoscopy - a randomized study. Turk J Gastroenterol: 2008; 19 174 179
37. Chaptini LA, Janec EM, Seltzer G et al. Sublingual hyoscyamine spray as premedication for colonoscopy: a randomized double-blinded placebo-controlled trial. Am J Surg: 2008; 196 51 55
38. Dumot JA, Verzola E, Nicol S et al. Sublingual hyoscyamine for patient comfort during screening sigmoidoscopy: a randomized, double-blind, placebo-controlled clinical trial. Gastrointest Endosc: 1998; 48 283 286
39. Marshall JB, Patel M, Mahajan RJ et al. Benefit of intravenous antispasmodic (hyoscyamine sulfate) as premedication for colonoscopy. Gastrointest Endosc: 1999; 49 720 726
40. Mui LM, Ng EK, Chan KC et al. Randomized, double-blinded, placebo-controlled trial of intravenously administered hyoscine N-butyl bromide in patients undergoing colonoscopy with patient-controlled sedation. Gastrointest Endosc: 2004; 59 22 27
41. Norfleet RG. Premedication for colonoscopy: Randomized, double-blind study of glucagon versus placebo. Gastrointest Endosc: 1978; 24 164 165
42. Norfleet RG, Saviage K. Atropine premedication for colonoscopy: a randomized double-blind study. Gastrointest Endosc: 1983; 29 157
43. Waxman I, Mathews J, Gallagher J et al. Limited benefit of atropine as premedication for colonoscopy. Gastrointest Endosc: 1991; 37 329 331
44. Yoong KY, Perkin D, Portal J et al. Intravenous hyoscine as a premedication for colonoscopy: a randomized double-blind controlled trial. Endoscopy: 2004; 36 720 722
45. Yoshikawa I, Yamasaki M, Taguchi M et al. Comparison of glucagon and scopolamine butylbromide as premedication for colonoscopy in unsedated patients. Dis Colon Rectum: 2006; 49 1393 1398
46. Cutler CS, Rex DK, Hawes RH, Lehman GA. Does routine intravenous glucagon administration facilitate colonoscopy? A randomized trial. Gastrointest Endosc: 1995; 42 346 350
47. Bond JH, Chally CH, Blackwood WD. A controlled trial of premedication with dicyclomine hydrochloride (Bentyl) in colonoscopy. Gastrointest Endosc: 1974; 21 61
48. Elphick DA, Donnelly MT, Smith KS, Riley SA. Factors associated with abdominal discomfort during colonoscopy: a prospective analysis. Eur J Gastroenterol Hepatol: 2009; 21 1076 1082
49. Lee YC, Wang HP, Chiu HM et al. Factors determining post-colonoscopy abdominal pain: prospective study of screening colonoscopy in 1000 subjects. J Gastroenterol Hepatol: 2006; 21 1575 1580
50. Takahashi Y, Tanaka H, Kinjo M, Sakumoto K. Prospective evaluation of factors predicting difficulty and pain during sedation-free colonoscopy. Dis Colon Rectum: 2005; 48 1295 1300
51. Ansari A, Soon SY, Saunders BP, Sanderson JD. A prospective study of the technical feasibility of ileoscopy at colonoscopy. Scand J Gastroenterol: 2003; 38 1184 1186
52. Misra SP, Dwivedi M. Role of intravenously administered hyoscine butyl bromide in retrograde terminal ileoscopy: a randomized, double-blinded, placebo-controlled trial. World J Gastroenterol: 2007; 13 1820 1823
53. Tee HP, Corte C, Al-Ghamdi H et al. Prospective randomized controlled trial evaluating cap-assisted colonoscopy vs standard colonoscopy. World J Gastroenterol: 2010; 16 3905 3910
54. Ell C, Fischbach W, Bronisch HJ et al. Randomized trial of low-volume PEG solution versus standard PEG + electrolytes for bowel cleansing before colonoscopy. Am J Gastroenterol: 2008; 103 883 893
55. Rex DK, Bond JH, Winawer S et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol: 2002; 97 1296 1308
56. de Wijkerslooth TR, Stoop EM, Bossuyt PM et al. Adenoma detection with cap-assisted colonoscopy versus regular colonoscopy: a randomised controlled trial. Gut In press 2011 10.1136/gutjnl-2011-301327
57. Cooper GS, Chak A, Koroukian S. The polyp detection rate of colonoscopy: a national study of Medicare beneficiaries. Am J Med: 2005; 118 1413
58. Kaltenbach T, Friedland S, Soetikno R. A randomised tandem colonoscopy trial of narrow band imaging versus white light examination to compare neoplasia miss rates. Gut: 2008; 57 1406
59. DeMarco DC, Odstrcil E, Lara LF et al. Impact of experience with a retrograde-viewing device on adenoma detection rates and withdrawal times during colonoscopy: the Third Eye Retroscope study group. Gastrointest Endosc: 2010; 71 542 550
60. Munroe CA, Lee P, Copland A et al. A tandem colonoscopy study of adenoma miss rates during training: a venture into uncharted territory. Gastrointest Endosc: 2012; 75 561 567
61. Francis DL, Rodriguez-Correa DT, Buchner A et al. Application of a conversion factor to estimate the adenoma detection rate from the polyp detection rate. Gastrointest Endosc: 2011; 73 493 497